Aurora Cannabis (ACB) (ACBFF) stock rose by 9.9% to its highest level of 15.1 Canadian dollars on October 15. With just one more day until recreational cannabis will be sold legally in Canada, investors (HMLSF) are hopeful that Aurora Cannabis will emerge as a strong player.
Overall, the current consensus analyst recommendation for Aurora Cannabis in October is a “buy,” which remained unchanged from September. As the chart above shows, two analysts maintained a “strong buy” recommendation on the stock, while one analyst maintained a “buy” recommendation on the stock. Also, one analyst maintained a “hold” recommendation on Aurora Cannabis. Unlike Canopy Growth (CGC) (WEED), none of the analysts had a “sell” recommendation on Aurora Cannabis in October.
The current mean price target on the stock in October was 10.9 Canadian dollars, which rose from 10.1 Canadian dollars in September. The median price target on the stock was also higher at 11 Canadian dollars, which increased from 9 Canadian dollars a month ago. Aurora Cannabis stock closed almost 37% higher from the current price target, which indicates that the market is more optimistic than analysts.
Next, we’ll discuss Cronos Group (CRON).